Menopause facial hair: why it arrives at the same time your scalp hair thins
Estrogen and progesterone hold androgen activity in check throughout the reproductive years. When both fall away in perimenopause, testosterone output barely changes, so the same amount of androgen signal starts landing on tissue that no longer has anything opposing it. On the face, that signal turns fine, pale vellus hair into coarse, pigmented terminal hair. In a cross-sectional study of 758 postmenopausal women published in the British Journal of Dermatology, 49% reported new facial hair growth.
The detail that rarely gets mentioned is what the same study found about the scalp. Forty-one percent of those women also reported hair loss, and the ones with frontal thinning had the highest facial hair scores of anyone in the cohort. The chin and the crown are not two separate problems arriving at an unlucky moment. They are the same hormonal shift showing up in two places, because follicles in each location respond to androgens in opposite directions.
This article explains what happens to the estrogen and androgen balance after 40, why facial follicles coarsen while scalp follicles shrink, what the evidence supports for each side of that shift, and how the available treatment options compare.
- What happens to the estrogen and androgen balance after 40
- Why the chin gains hair while the crown loses it
- What the evidence supports for androgen-driven hair changes
- Hair removal, prescriptions, and where each one acts
- Supporting the scalp side of the shift with Botavive Glow
- Frequently asked questions
| What changes | Why it matters |
|---|---|
| Estrogen falls while testosterone holds steady | The ratio shifts toward androgens without any rise in testosterone, which is why standard bloodwork usually reads as normal |
| 49% of postmenopausal women report new facial hair | Of those, 39% noticed it on the chin only, 22% on the upper lip only, and 39% in both areas |
| Facial and scalp changes cluster together | Women with frontal scalp thinning carried the highest facial hair scores, pointing to one shared driver |
| Vellus hair converts to terminal hair | The follicle is not new, it has switched output from fine and pale to coarse and pigmented, so the change looks sudden |
| Hormone therapy showed no measurable effect on facial hair scores | In the same cohort, users and non-users scored alike, so HRT should not be expected to resolve this symptom |
| Rapid onset is a different situation | Fast-appearing hair with voice deepening or acne warrants androgen testing rather than cosmetic management |
What happens to the estrogen and androgen balance after 40
Androgens are not a male hormone that women happen to carry a little of. Testosterone circulates in every woman throughout life, produced by the ovaries and the adrenal glands, and it does necessary work in muscle, bone, libido and mood. What keeps its effects on skin and hair restrained is estrogen, which both opposes androgen activity at the tissue level and raises sex hormone binding globulin, the protein that ties up circulating testosterone and keeps it inactive.
Through perimenopause, ovarian estrogen production declines steeply. Adrenal androgen output declines too, but gradually, and it starts from a base that is far less dependent on ovarian function. The result is arithmetic rather than pathology. Total testosterone often sits squarely within the reference range while the proportion of it that is unbound rises and the estrogen holding it in check falls away. The StatPearls clinical reference describes this state in postmenopausal women as relative hyperandrogenism, driven by the cessation of ovarian estrogen production rather than by any excess androgen production.
The step that converts a circulating hormone into a visible hair is enzymatic and happens inside the skin. An enzyme called 5-alpha-reductase, present in the hair follicle and sebaceous gland, converts testosterone into dihydrotestosterone. DHT binds androgen receptors far more tightly than testosterone does and produces a stronger signal at the follicle. Two women with identical blood levels will experience different outcomes depending on how much 5-alpha-reductase their skin produces and how densely their follicles carry androgen receptors, both of which are inherited.
What that signal does at the face is a conversion, not a creation. Every follicle on the chin and upper lip has been there since before puberty, producing vellus hair: short, fine, unpigmented, essentially invisible. Sustained androgen exposure switches those follicles to terminal output, meaning longer, thicker, darker and coarser. Nothing new has grown. Existing follicles changed what they were making, which is why the appearance of chin hairs feels abrupt to the woman experiencing it even though the hormonal change behind it took years.
The clinical name for coarse hair growing in an androgen-dependent, male-typical pattern is hirsutism, and it is graded with the Ferriman-Gallwey scale, which scores nine body areas from zero to four. Most of the postmenopausal facial hair women describe in support groups sits at the mild end of that scale. It is a cosmetic and emotional problem rather than a medical one, and understanding that it comes from a ratio rather than a surplus explains why so many women are told their hormone panel looks fine.
Why the chin gains hair while the crown loses it
The same molecule producing coarse hair on the jaw is shrinking follicles on the top of the head. This is the part that feels like a cruel joke and is the single most useful thing to understand about hair after 40.
Follicles are regionally programmed. Androgen receptors are distributed unevenly across the body, and the follicles that carry them respond to the same DHT signal in directly opposite ways depending on where they sit. Beard-area follicles on the chin, jaw and upper lip are androgen-dependent, meaning DHT drives them from vellus to terminal. Follicles at the crown and along the part line are androgen-sensitive in the opposite sense: DHT shortens their growth phase and shrinks them a little more with every cycle. The follicles at the nape and sides carry few androgen receptors, which is why that hair stays dense and why it is used as the donor area in transplantation.
This is why the two symptoms travel together. The 758-woman cohort found that women with frontal scalp hair loss had higher facial hair scores than women with diffuse all-over thinning, and were also younger on average. Two distinct patterns emerged from that data: diffuse scalp loss that tracked with age and general body hair loss, and frontal loss that tracked with facial hair gain. The second pattern is the androgenic one. If you are noticing your part widening and new chin hairs in the same year, you are seeing one process, not two.
Hormone therapy does not reliably change it. In that same study, twenty percent of participants were current hormone users and a further twenty-two percent were past users, and there was no measurable difference in facial hair scores between users and non-users. Systemic estrogen addresses vasomotor symptoms and bone density well. It does not appear to reverse follicle conversion that has already happened, partly because terminal hair, once established, tends to stay terminal.
Several other things push in the same direction. Insulin resistance raises free testosterone by lowering sex hormone binding globulin, and it becomes more common after menopause as body composition shifts. Weight gain around the middle adds to this, and the Cleveland Clinic notes that losing even 5% of body weight lowers androgen levels. Sun exposure darkens existing hair and the skin around it, which makes upper lip hair look more pronounced than the actual growth would suggest. None of these creates the underlying shift, but each one makes the visible result worse.
What the evidence supports for androgen-driven hair changes
Honesty matters more here than in most symptom categories, because the gap between what is marketed and what is demonstrated is unusually wide. Nothing available over the counter reverses terminal hair back to vellus. What the evidence supports is influencing the hormonal environment, slowing the conversion of additional follicles, and supporting the scalp side of the same shift where the opportunity is genuinely better.
Spearmint. The most cited botanical for this, and worth reporting accurately rather than as the miracle it gets sold as. A 30-day randomized controlled trial of 42 women with polycystic ovary syndrome, published in Phytotherapy Research in 2010, found that spearmint tea taken twice daily lowered both free and total testosterone measurably against placebo. Participants also rated their own hirsutism as improved. The objective Ferriman-Gallwey scores, though, did not differ between groups at 30 days. The authors attributed that to the study being far shorter than a hair growth cycle. So the anti-androgen effect on bloodwork is real and documented, the visible effect on hair within a month is not, and the trial was conducted in premenopausal women with PCOS rather than in postmenopausal women.
Blood sugar and insulin. The best-supported lever, and the least glamorous. Insulin resistance suppresses sex hormone binding globulin, which raises the fraction of testosterone circulating free and available to reach the follicle. Improving insulin sensitivity through resistance training, adequate protein and reduced refined carbohydrate raises SHBG and lowers free androgen. This is slow and unglamorous and it addresses the mechanism rather than the surface.
Protein and the scalp side. While facial follicles need no help, scalp follicles under the same androgen pressure are working with fewer resources. Hair is roughly 95% keratin, protein intake often drops in midlife as appetite and portion sizes change, and requirements move the other way because protein synthesis becomes less efficient with age. Adequate protein spread across the day supports the follicles that are losing ground.
Iron. Ferritin deserves testing before anything else if scalp thinning is part of the picture. Perimenopausal bleeding is frequently heavier, iron stores drop, and low ferritin produces diffuse shedding that compounds the androgenic thinning underneath it. Correcting a confirmed deficiency produces visible regrowth. No other intervention compensates for one left uncorrected.
Collagen and the dermal layer. Estrogen loss reduces skin collagen content measurably in the years after menopause, and the dermal layer surrounding each follicle is largely collagen. That layer anchors and supplies the follicle, so its decline affects scalp hair independently of the hormone signal reaching the follicle itself. Collagen peptides supply the proline and glycine that layer is built from.
Pro Tip: Give any approach aimed at the hormonal environment a minimum of six months before judging it, because a facial hair follicle completes a full cycle in roughly four to six months and the hair currently on your chin was committed to months ago. The spearmint trial failed to show an objective result largely because it stopped at thirty days.
Hair removal, prescriptions, and where each one acts
Facial hair after menopause is managed at two different levels, and confusing them is where most frustration comes from. Removal methods address the hair that already exists. Hormonal approaches address whether more follicles convert. Neither substitutes for the other, and most women end up using something from each column.
The Cleveland Clinic sets realistic expectations on the removal side. Laser hair removal typically requires six to eight sessions spaced six to eight weeks apart, and it works by targeting pigment, so it performs poorly on the white and grey hairs that become common after 50. Electrolysis works regardless of hair color because it destroys the follicle electrically rather than optically, but treatment often continues for up to a year and a half. Eflornithine cream slows growth rather than removing hair, takes six to eight weeks to show an effect, and growth returns to baseline once it is stopped.
| Approach | Pros | Considerations | Best for |
|---|---|---|---|
| Tweezing, waxing, threading | Immediate, inexpensive, done at home, results last three to six weeks | Skin irritation and ingrown hairs, and thinner postmenopausal skin bruises more easily with waxing | A small number of isolated chin or lip hairs |
| Laser and IPL | Long-lasting reduction over a course of treatment, covers a wider area efficiently | Targets pigment, so it fails on white or grey hair, and needs six to eight sessions | Dark hair on lighter skin, caught before it greys |
| Electrolysis | Works on any hair color including white, and destroys the follicle permanently | Treats one follicle at a time, and a course often runs eighteen months | Coarse white or grey hair that laser cannot reach |
| Prescription anti-androgens | Acts on the androgen signal itself rather than the visible hair | Prescription only, needs monitoring, and takes one to two years to show effect | Documented androgen excess under specialist care |
| Metabolic and nutritional support | Addresses free testosterone via SHBG, with benefits across other menopause symptoms | Slow, requires consistency, and does not reverse hair that is already terminal | Anyone managing scalp thinning alongside facial hair |
The sequence that makes practical sense for most women is to handle the existing hair cosmetically without guilt, since that is what removal methods are for, while working on the hormonal environment to reduce how many additional follicles convert over the coming years. Treating the two as competing options leads to disappointment in both directions: nutrition will not remove a chin hair, and electrolysis will not stop the next one from arriving.
One practical note on the scalp side. Because the same androgen shift is thinning the crown, the effort spent on ferritin, protein and the follicle environment pays off there rather than on the face. The scalp follicles are still alive and still producing, and a miniaturizing follicle responds to a better environment in a way that a converted beard follicle does not.
Know when to seek professional evaluation:
- Facial hair appearing rapidly over weeks or a few months rather than gradually over years
- Hair growth alongside voice deepening, increased muscle bulk, or clitoral enlargement, which points to a possible androgen-secreting source
- New facial hair with sudden severe acne and scalp hair loss appearing together
- Any facial hair change accompanied by unexplained weight gain, easy bruising, or new high blood pressure
- Coarse hair spreading to the chest, upper back or abdomen rather than staying on the face
- Distress about appearance that is affecting your sleep, mood, or willingness to see people
Supporting the scalp side of the shift with Botavive Glow
No supplement removes facial hair, and any product suggesting otherwise is worth walking away from. What deserves attention is the other half of the same hormonal change, where the follicles are still active and the opportunity is real. The women describing chin hairs in support groups almost always describe a widening part in the same breath, and that is the part that responds to support.
Botavive Glow for Hair, Skin and Nails was formulated around the follicle environment rather than around a single high-dose vitamin. It combines hydrolyzed collagen, which supplies the proline and glycine used in the dermal layer surrounding each follicle, hyaluronic acid for hydration in that same layer, horsetail extract as a source of plant silica for structural support, and biotin at a level that covers requirement without the high doses that interfere with thyroid and cardiac laboratory assays. After 40 the environment around the follicle changes as much as the follicle itself, and supporting one without the other leaves half the problem untouched.
It belongs alongside the rest of the approach rather than in place of it. Have ferritin and thyroid tested first, keep protein adequate and spread across the day, manage the facial hair cosmetically in whatever way suits you, and give any nutritional support a full hair cycle before drawing conclusions.
Frequently asked questions
Why do I have new facial hair when my testosterone came back normal?
Because the driver is a ratio, not a surplus. Testosterone stays roughly level through menopause while estrogen falls away, so the same reading that raised no flags at 35 produces a much stronger effect at 55. Sex hormone binding globulin also drops, which raises the unbound fraction available to reach the follicle. A standard panel measures the total and reports it as normal, which is accurate and beside the point.
Will hormone therapy make it go away?
The evidence does not support expecting that. In the 758-woman cohort, facial hair scores showed no measurable difference between current hormone users, past users and never users. Hormone therapy has strong support for hot flashes, night sweats and bone density. Reversing follicles that have already converted from fine hair to coarse hair is not something it reliably does.
Does plucking or shaving make it grow back thicker?
No. Shaving cuts the strand at an angle across its widest point, which makes regrowth feel blunt and coarse against the fingertip, but it does not change the follicle or what it produces. Plucking removes the hair from the root and results last three to six weeks. Repeated plucking of the same follicle sometimes causes irritation or ingrown hairs, which is a reason to be gentle, not a reason to expect thicker growth.
Does spearmint tea work?
Partly, and less than the internet claims. The randomized trial behind the reputation found measurably lower free and total testosterone after 30 days of twice-daily spearmint tea, which is a real anti-androgen effect. The objective hirsutism scores did not improve over that period, most likely because 30 days is far shorter than a hair cycle. The trial was also run in premenopausal women with polycystic ovary syndrome, so applying it directly to postmenopausal women involves an assumption the data does not cover.
Is it more common in perimenopause or after menopause?
Both, with different character. Facial hair gain tends to track with frontal scalp thinning and appears in women who are younger within the postmenopausal range, which is the androgenic pattern. Growth continues to be reported well into the postmenopausal years, though the frequency does not climb steadily with age. If it starts in your early forties alongside a widening part, that is the recognizable androgenic presentation rather than anything unusual.
Sources
- International Menopause Society, 2011. Commentary on Ali and Wojnarowska, a cross-sectional study of 758 postmenopausal women finding 49% reported facial hair gain and 41% reported scalp hair loss, with frontal loss associated with higher facial hair scores. imsociety.org
- Sharma L and Kaur J, 2023. Hirsutism, StatPearls. Describes postmenopausal relative hyperandrogenism from cessation of ovarian estrogen production, and the role of 5-alpha-reductase in converting testosterone to DHT at the follicle. ncbi.nlm.nih.gov
- Cleveland Clinic, 2022. Hirsutism. Covers the Ferriman-Gallwey scale, the effect of 5% weight loss on androgen levels, and expected timelines for laser, electrolysis and eflornithine. my.clevelandclinic.org
- Grant P, 2010. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome, a randomized controlled trial. Phytotherapy Research, 24, 186 to 188.